Editors for Epidemiology and Global Health
Senior editors
-
Balram Bhargava
Indian Council of Medical Research, India
Dr Bhargava is the Director General of the Indian Council of Medical Research (ICMR) Secretary, Department of Health Research, (Ministry of Health & Family Welfare), Government of India.
Professor (Dr) Balram Bhargava was born in Lucknow 21st July 1961. He received all his medical training at the King George Medical College, Lucknow. Further, he received advanced training at the Gardiner Institute, University of Glasgow and the Washington Heart Centre, Washington DC.
Balram Bhargava is Professor of Cardiology at the All India Institute of Medical Sciences, New Delhi, and also serves as the Executive Director for Stanford India Biodesign Centre, School of International Biodesign (SiB).
He is a cardiologist at the forefront of biomedical innovation, public health, medical education, and medical research. He directs the School of International Biodesign at AIIMS, an interdisciplinary programme to foster innovation and design of low-cost implants and devices which has led to more than thirty patents on low-cost medical devices and a dozen start-ups. He developed the indigenous Platinum Iridium coil coronary stent and has been instrumental in clinically evaluating and establishing medicated Indian stents. He has led innovations initiatives, such as Society for Less Investigative Medicine (SLIM). He is currently providing leadership for creative disease prevention, early detection, and transport system for sick cardiac patients (mission DELHI (Delhi Emergency Life Heart-Attack Initiative) by trained motorcycle first responder Paramedics).
Professor Bhargava was awarded the Padma Shri by the Indian government for his contributions to medicine. He is also been awarded the SN Bose Centenary Award by the Indian National Science Congress, the National Academy of Sciences Platinum Jubilee Award, the Tata Innovation Fellowship, Vasvik Award for Biomedical Technology Innovation, the Ranbaxy Award, OP Bhasin Award in the field of Health and Medical Sciences and more recently the UNESCO Equatorial Guinea Prize for Life Sciences. Dr Lee Jong-Wook Memorial Prize for Public Health, 2019 by WHO Hqrs, Geneva and received President’s Medal Award from Royal College of Physicians and Surgeons of Glasgow, UK for his research in ‘Frugal Innovations’ in February 2020.
- Expertise
- Medicine
- Epidemiology and Global Health
- Research focus
- interventional cardiology
- stents
- restenosis
- coronary artery disease
- risk factors of valvular heart disease
- interventions of rheumatic heart disease
- epidemiology
- non-communicable disease
- infectious disease
- health policy
- public health
- Experimental organism
- human
- Competing interests statement
- Dr Bhargava is the founding editor of the British Medical Journal Innovations (BMJi) until 2018, and he is currently the Editor-in-Chief of the Indian Journal of Medical Research.
-
Miles P Davenport
University of New South Wales, Australia
Miles Davenport is Professor of Medicine and Head of the Infection Analytics Program at the Kirby Institute for Infection and Immunity at UNSW Sydney. He graduated in medicine from the University of Sydney and completed his DPhil at the University of Oxford in immunology before retraining in mathematical biology. He leads a team of applied mathematicians who use statistical analysis and modelling to understand host-pathogen interactions in infection and immunity. This involves collaboration with a wide variety of experimental and clinical scientists both in Australian and internationally. Major areas of investigation include understanding HIV latency, malaria immunity and treatment, and neonatal immune development. He is a past-President of the Australasian Society for Immunology and is supported by an NHMRC (Australia) Investigator grant.
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Medicine
- Research focus
- virology
- immunity
- vaccines
- HIV/AIDS
- mathematical modelling
- host-pathogen interactions
- biostatistics
- Competing interests statement
- Miles Davenport receives funding from the National Health and Medical Research Council (Australia), the Australian Research Council, and the National Institutes of Health (USA). He is an Associate Editor at PLoS Computational Biology and on the Editorial Board of Immunology and Cell Biology.
-
Neil Ferguson
Imperial College London, United Kingdom
Neil Ferguson is Head of the Department of Infectious Disease Epidemiology at Imperial College London, where he leads the MRC Centre for Outbreak Analysis and Modelling. His research aims to improve the understanding of epidemiological factors and population processes that shape infectious disease spread in human and animal populations. A practical focus of his work is the analysis and optimisation of intervention strategies that are aimed at reducing transmission or disease burden.
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology and infectious disease
- emerging infections
- mosquito-borne infections
- statistical and mathematical tools
-
Eduardo Franco
McGill University, Canada
Eduardo Franco is Professor and Chairman, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal. He holds BSc (1975) and Licentiate (1976) degrees in biology from Universidade de Campinas, Brazil, and master's (MPH) and doctoral (DrPH) degrees in public health microbiology from the University of North Carolina at Chapel Hill (1981-84). He was a Guest Researcher at the US Centers for Disease Control in Atlanta (1980-81 and 1983-84), and a post-doctoral fellow in cancer epidemiology during 1984 at the International Agency for Research on Cancer in Lyon, France, at the US National Cancer Institute (NCI) in Bethesda, and at Louisiana State University, in New Orleans. Since 1985, he has conducted epidemiologic research on the causes of cancer and on the means to prevent it or to improve patient survival. He is mostly known for his contributions to our understanding of human papillomavirus infection as the cause of cervical cancer and using this knowledge to prevent this cancer via vaccination and improved screening strategies. He received the Canadian Cancer Research Alliance’s Distinguished Service to Cancer Research Award, Lifetime Achievement Awards from the American Society for Colposcopy and Cervical Pathology and from the International Papillomavirus Society, the Women in US Government’s Leadership Award, the Canadian Cancer Society’s Warwick Prize, the Geoffrey Howe Outstanding Contribution Award from the Canadian Society for Epidemiology and Biostatistics, the University of British Columbia’s Chew Wei Memorial Prize in Cancer Research, and the McLaughlin-Gallie Award from the Royal College of Physicians of Canada. He has mentored 115 graduate students and post-doctoral fellows, and 30 undergraduate trainees. He is Officer of the Order of Canada and Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. Heholds an honorary doctorate from Universidade Fernando Pessoa, Porto, Portugal.
- Expertise
- Cancer Biology
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer epidemiology
- cancer prevention
- human papillomavirus
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Entire research program funded by the Medical Research Council of Canada (until 1999), Canadian Institutes of Health Research (CIHR) (1999-present), National Institutes of Health, Canadian Cancer Society, and Cancer Research Society. He has received salary awards from the Fonds de Recherche Quebec Santé and CIHR. He holds a James McGill Professorship and the Minda de Gunzburg Endowed Chair at McGill University. He serves as Editor-in-Chief for Preventive Medicine and Preventive Medicine Reports and serves on the editorial boards of Cancer Epidemiology, Biomarkers & Prevention, International Journal of Cancer, Papillomavirus Research, and Salud Publica de Mexico. He has served as occasional consultant to companies involved with HPV vaccination (Merck and GSK) and HPV diagnostics (Roche, Abbott, Qiagen, and BD).
-
Diane M Harper
University of Michigan, United States
Diane M Harper, MD, MPH, MS, completed her undergraduate and graduate degrees at the Massachusetts Institute of Technology in Cambridge, Massachusetts, in the fields of Chemical Engineering and Polymerics. She received her medical and public health degrees from the University of Kansas in Kansas City, where she also did residencies in Gynecology/Obstetrics and Family Medicine. Dr Harper has spent the majority of her professional career at Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, as clinician, teacher and researcher in the Departments of Obstetrics and Gynecology, Community and Family Medicine and Women’s and Gender Studies, including improving life for LGBTQ.
She has received the Society of Teachers of Family Medicine (STFM) Excellence in Education Award and the Curtis Hames Research Award honoring her for changing medical care for women through evidence based research. She served as the Chair of Family and Geriatric Medicine at the University of Louisville during which time she also served on the United States Preventive Services Task Force.
She currently is a tenured Professor at the University of Michigan, serving as the Director for Research Management within the Michigan Institute of Clinical and Health Research, one of 50 Clinical and Translational Science Award Research Hubs across the United States. To date she has over 250 peer reviewed publications with over 27,000 citations, and over 40,000 downloads of her seminal review of HPV vaccines.
While at Dartmouth she developed and directed the Gynecologic Cancer Prevention Research Group based at the Norris Cotton Cancer Center in which research on all aspects of HPV associated diseases, specifically cervical cancer prevention was conducted. She is an internationally recognized expert on Human Papillomavirus, the cause of cervical cancer, and its prophylactic and therapeutic vaccines. She has published the seminal clinical research on HPV vaccines and lectured internationally in over 100 countries. She has served on NCI research committees, European research study sections, addressed the Council on Foreign Affairs, and served as a technical advisor to the World Health Organization. Dr Harper has been honored as one of the top clinicians in her field in the US, and Family Physician of the Year in New Hampshire in 2006.
- Expertise
- Medicine
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Research focus
- HPV associated diseases
- primary care
- women's health
- cancer precursor detection
- health behaviours
- epidemiology
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Diane Harper has received funding from NCI, NCATS, NHLBI, CDC, multiple national philanthropic organizations, including the American Cancer Society, The Robert Wood Johnson Foundation, and the Susan G Komen Foundation, in addition to state and local funding agencies and collaborations with industry. She serves in editorship capacities on boards including the Annals of Family Medicine, Preventive Medicine Reports, PLoS ONE, and Gynecologic Oncology. She is a peer reviewer for The Lancet, The New England Journal of Medicine, JAMA, among other journals.
Reviewing editors
-
David B Allison
Indiana University, United States
- Expertise
- Medicine
- Genetics and Genomics
- Epidemiology and Global Health
- Computational and Systems Biology
- Evolutionary Biology
- Research focus
- experimental design
- statistics
- longevity
- biostatistics
- obesity
- nutrition
- senescence
- research rigour
- science integrity
-
Muthuswamy Balasubramanyam
ICMR Emeritus Scientist, Madras Diabetes Research Foundation, India
- Expertise
- Medicine
- Biochemistry and Chemical Biology
- Cancer Biology
- Cell Biology
- Developmental Biology
- Epidemiology and Global Health
- Genetics and Genomics
- Immunology and Inflammation
- Neuroscience
- Stem Cells and Regenerative Medicine
- Research focus
- disease biology
- diabetes
- aging
- omnics
- calcium signaling
- endocrine disruptors
- probiotics
- molecular medicine
-
Marc J Bonten
University Medical Center Utrecht, Netherlands
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology
- antibiotic resistance
- healthcare-associated infections
- prevention
- clinical trials
-
Philip Boonstra
University of Michigan, United States
- Expertise
- Medicine
- Epidemiology and Global Health
- Cancer Biology
- Genetics and Genomics
- Research focus
- biostatistics
- clinical trials
- cancer biostatistics
- epidemiology
- ECMO
- statistical programming
-
Charlotte Cecil
Erasmus MC, Netherlands
- Expertise
- Neuroscience
- Epidemiology and Global Health
- Genetics and Genomics
- Research focus
- epigenetics
- DNA methylation
- psychiatric disorders
- development
- (early life) stress
- epidemiology
- birth cohort
- child mental health
-
Christine Clayton
Zentrum fuer Molekulare Biologie der Universitaet Heidelberg (ZMBH), Germany
- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Research focus
- trypanosomes
- mRNA degradation
- RNA-binding proteins
-
Sarah E Cobey
University of Chicago, United States
- Expertise
- Microbiology and Infectious Disease
- Ecology
- Evolutionary Biology
- Epidemiology and Global Health
- Medicine
- Research focus
- B cells
- coevolution
- infectious disease dynamics
- influenza
- mathematical modelling
- vaccination
-
Caroline Colijn
Simon Fraser University, Canada
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- evolution of pathogens
- pathogen ecology
- mathematics
- epidemiological modelling
-
Alex R Cook
National University of Singapore, Singapore
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- infectious disease epidemiology
- mathematical modelling
- biostatistics
- health policy
-
Ben Cooper
Mahidol Oxford Tropical Medicine Research Unit, Thailand
- Expertise
- Computational and Systems Biology
- Epidemiology and Global Health
- Research focus
- population biology of communicable diseases
- antimicrobial resistance
- epidemiological methods
-
Jennifer Cullen
Case Western Reserve University, United States
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer population sciences
-
Joris Deelen
Max Planck Institute for Biology of Ageing, Germany
- Expertise
- Epidemiology and Global Health
- Genetics and Genomics
- Research focus
- aging
- longevity
- age-related diseases
- genetics
- functional characterization of genetic variants
- CRISPR/Cas9
- biomarkers of aging
- biology of aging
- Experimental organism
- mouse
- human
-
Marcelo U Ferreira
University of São Paulo, Brazil
- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Research focus
- infectious diseases
- malaria
- parasites
- epidemiology
- population genomics
- genomics
- control
-
Jennifer Flegg
University of Melbourne, Australia
- Expertise
- Computational and Systems Biology
- Epidemiology and Global Health
- Research focus
- mathematical modelling
- mathematical biology
- computational biology
- infectious disease dynamics
-
Sara Hägg
Karolinska Institutet, Sweden
- Expertise
- Epidemiology and Global Health
- Genetics and Genomics
- Research focus
- aging
- gerontology
- biomarkers of aging
- biological age
- molecular epidemiology
- Experimental organism
- human
-
Edward D Janus
University of Melbourne, Australia
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cardiovascular disease
- diabetes
- prevention
- chronic diseases
- clinical guidelines
-
Prabhat Jha
Saint Michael's Hospital, Canada
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology
- global health
- infectious disease and population dynamics
- randomized controlled trials
-
Mark Jit
London School of Hygiene & Tropical Medicine, and Public Health England, United Kingdom
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- vaccines
- infectious disease epidemiology
- mathematical modelling
- health economics
- low- and middle-income countries
- Experimental organism
- human
- vaccine-preventable pathogens
- human papillomavirus
- measles virus
- rotavirus
- influenza virus
- S. pneumoniae
-
Urszula Krzych
Walter Reed Army Institute of Research, United States
- Expertise
- Epidemiology and Global Health
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- adoptive immunity
- immune memory responses
- liver resident T memory cells
- Plasmodium liver stage infection
- Plasmodium antigens/vaccines
- design of malaria vaccines
-
Hongliang Li
Wuhan University School of Medicine, China
- Expertise
- Biochemistry and Chemical Biology
- Computational and Systems Biology
- Epidemiology and Global Health
- Immunology and Inflammation
- Medicine
- Research focus
- cardiometabolic disease
- metabolic disease
- vascular injury
- animal models
- liver
- innate immunity
-
Elham Mahmoudi
University of Michigan, United States
- Expertise
- Medicine
- Epidemiology and Global Health
- Research focus
- health services research
- large data analysis
- econometrics and methodology
- economics of dementia
- economics of aging
- disability
- healthcare cost and utilization
- disparity in health and healthcare
-
Talía Malagón
McGill University, Canada
- Expertise
- Epidemiology and Global Health
- Research focus
- human papillomavirus
- cervical cancer
- screening
- vaccination
- mathematical modelling
- cancer epidemiology
- sexually transmitted infections
-
James M McCaw
The University of Melbourne, Australia
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Ecology
- Immunology and Inflammation
- Research focus
- mathematical epidemiology
- virus dynamics
- infectious diseases
- mathematical modelling
- pandemics
- influenza
- malaria
- COVID-19
-
Belinda Nicolau
McGill University, Canada
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer epidemiology
- social determinants of health
-
C. Brandon Ogbunugafor
Yale University, United States
- Expertise
- Computational and Systems Biology
- Evolutionary Biology
- Epidemiology and Global Health
- Physics of Living Systems
- Microbiology and Infectious Disease
- Research focus
- disease ecology
- microbial evolution
- population genetics
- epidemiology
- evolutionary medicine
- Experimental organism
- E. coli
- human
- P. falciparum
- S. cerevisiae
- viruses
-
Isabel Rodriguez-Barraquer
University of California, San Francisco, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- dengue
- malaria
- Zika
- vector-borne diseases
- serology
- modeling
- Experimental organism
- human
-
Joshua T Schiffer
Fred Hutchinson Cancer Research Center, United States
- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Immunology and Inflammation
- Medicine
- Research focus
- mathematical modelling
- herpesviruses
- HIV
- COVID-19
- T cell immunology
- Experimental organism
- human
- viruses
- HSV
- SARS-CoV-2
-
Nicolas Schlecht
Roswell Park Comprehensive Cancer Center, United States
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer prevention
- cancer control
-
Viviana Simon
The Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- viral-host interactions
- retroviral restriction factors
- HIV drug resistance
-
Mashaal Sohail
National Autonomous University of Mexico, Mexico
- Expertise
- Computational and Systems Biology
- Evolutionary Biology
- Genetics and Genomics
- Epidemiology and Global Health
- Research focus
- population genetics
- complex traits
- natural selection
- population structure
- demographic history
- genomics
- equity
- anthropological genetics
-
Margaret Stanley
University of Cambridge, United Kingdom
- Expertise
- Cancer Biology
- Microbiology and Infectious Disease
- Medicine
- Epidemiology and Global Health
- Research focus
- vaccines
- cervix cancer
- cervix precancer
- keratinocyte biology
- human papillomavirus
- DNA viruses
- vaccine immunology
- Experimental organism
- human
-
Shuo Su
Nanjing Agricultural University, China
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- evolutionary biology
- receptor
- protein interactions
- epidemics
- epidemic modelling
- virus evolution and diversity
-
Amy Wesolowski
Johns Hopkins Bloomberg School of Public Health, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- infectious diseases
- mobility
- malaria
- parasites
- measles
